Chase Therapeutics' Series B Round

Chase Therapeutics raised a round of funding on August 28, 2018.

Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease.…

Articles about Chase Therapeutics' Series B Round: